New Ray Medicine International Holding Limited

Research New Ray Medicine International Holding Limited (6108.HK) on Bullrun: market cap HKD 46.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker6108.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryPharmaceutical Retailers
CurrencyHKD
Market capHKD 46.54M
Financial periodFY2025
RevenueHKD 130.37M
Revenue growth38.8%
Net income-HKD 20.07M
Free cash flow-HKD 54.45M
Gross margin12.4%

Valuation Snapshot

latest market cap is HKD 46.54M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	HKD 130.37M	-HKD 20.07M	-HKD 54.45M	12.4%	n/a	HKD 29.42M	HKD 2.47M	HKD 424.22M
FY2024	HKD 93.95M	-HKD 31.01M	-HKD 5.39M	12.2%	-0.19	HKD 64.26M	HKD 3.55M	HKD 470.96M
FY2023	HKD 50.15M	-HKD 22.17M	-HKD 45.45M	25.8%	-0.13	HKD 103.95M	HKD 288.00K	HKD 480.25M
FY2022	HKD 89.77M	-HKD 77.95M	-HKD 9.02M	14.8%	-0.47	HKD 154.41M	HKD 1.28M	HKD 525.66M
FY2021	n/a	n/a	n/a	n/a	-0.02	n/a	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	HKD 46.54M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About New Ray Medicine International Holding Limited

New Ray Medicine International Holding Limited, an investment holding company, engages in distribution and trading of pharmaceutical and related products in the People's Republic of China. Its pharmaceutical products include levocarnitine injection for the treatment of muscular dystrophy, cardiomyopathy, acute and chronic myocardial infraction, angina pectoris, and parenteral nutrition;

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Kingworld Medicines Group Limited (1110.HK) Shanghai Pioneer Holding Ltd (1345.HK) Universal Health International Group Holding Limited (2211.HK) DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) Yifeng Pharmacy Chain Co., Ltd. (603939.SS) Fangzhou Inc. (6086.HK) JD Health International Inc. (6618.HK) YSB Inc. (9885.HK) Pomdoctor Ltd (POM) Ridgetech Inc (RDGT) Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ)

Frequently asked questions

What is New Ray Medicine International Holding Limited's market cap?

New Ray Medicine International Holding Limited's market capitalization is HKD 46.54M.

What does New Ray Medicine International Holding Limited do?

New Ray Medicine International Holding Limited, an investment holding company, engages in distribution and trading of pharmaceutical and related products in the People's Republic of China.